The Translational Impact of Model Organisms in Cancer
Conference - San Diego, CA, United States
The past decade has witnessed an enormous expansion in the variety, complexity and sophistication of model organisms of cancer. There are now available a plethora of models in a variety of organisms that recapitulate many important features of the cancers they are intended to emulate. This veritable explosion of new models reflects advances in our understanding of cancer mechanisms combined with technological advances in the generation of model organisms. These new model organisms are becoming well integrated with translational efforts to identify biomarkers of disease progression and outcome, to understand mechanisms of drug action, to investigate novel drug combinations and to study mechanisms of metastases and drug resistance. Model systems will include: mouse, dog, zebrafish, Drosophila and patient-derived xenografts. This meeting will highlight important recent advances in the use and complementarity of model organisms for translational research, as well as future directions and opportunities for successful translation from models to human clinical applications.
Organization: American Association for Cancer Research - AACR
(Courtesy of Model Organisms, via allthingsstemcell.com)
The Translational Impact of Model Organisms in Cancer
November 5-8, 2013
Omni San Diego, San Diego, CA
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
